✨ Free AI Report
Syngene International Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Syngene International Limited
Company Research

Syngene International Limited: Business Overview, Financials & Competitive Analysis

Syngene International Limited scores 7/10 on the AskCyborg Cyborg Score (Solid). Syngene benefits from secular outsourcing trends in pharma R&D with solid execution capabilities, though growth may face cyclical headwinds. Strong market position in growing CDMO/DDMS sector with recurring revenue from blue-chip clients. Faces competition from established global CDMOs and Indian peers but benefits from structural demand for outsourced R&D.

What is Syngene International Limited's industry? Syngene International Limited (syngeneintl.com) operates in Contract Research and Manufacturing Services (CDMO/DDMS). AskCyborg classifies Syngene International Limited under Contract Research and Manufacturing Services (CDMO/DDMS) in its company registry.

Syngene International is India's leading integrated drug discovery, development and manufacturing services (DDMS) provider. The company offers preclinical and clinical services to global pharmaceutical and biotech cli...

7/ 10Solid

Cyborg Score thesis

Syngene benefits from secular outsourcing trends in pharma R&D with solid execution capabilities, though growth may face cyclical...

Read the full analyst-debate transcript →
Industry Contract Research and Manufacturing Services (CDMO/DDMS)
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Syngene International Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Syngene International Limited

AskCyborg analysts argue the bull and bear cases for Syngene International Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Syngene International Limited OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Syngene International Limited Overview

Pro stress-test →

Syngene International is India's leading integrated drug discovery, development and manufacturing services (DDMS) provider. The company offers preclinical and clinical services to global pharmaceutical and biotech clients, positioning itself as a critical bridge between innovation and commercialization in the global life sciences ecosystem.

Strategic Profile

Pro stress-test →

Syngene competes on a platform model combining scientific expertise, regulatory capabilities, and manufacturing infrastructure for global pharma and biotech clients. Its competitive advantage lies in cost-effective execution, scientific quality, and established relationships with major pharmaceutical partners globally.

Competitive Landscape

Pro stress-test →

Syngene competes with global CDMOs like Lonza, Catalent, and Fareva, as well as Indian peers including Dr. Reddy's Labs and other CRO/CDMO providers. Differentiation comes through cost efficiency, scientific credibility, and dedicated focus on discovery and development services.

Industry Context

Syngene International Limited operates in Contract Research and Manufacturing Services (CDMO/DDMS).

Key facts

Founded: 1993 · Headquarters: Bangalore, India · Employees: 3,500 · Revenue: $450M · Market cap: $2.8B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Syngene International Limited.

  • Leading player in Indian CDMO/DDMS market with exposure to global pharmaceutical outsourcing trends
  • Diversified service portfolio reduces dependency on single client or therapeutic area
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Continued expansion of biologics and advanced formulation capabilities
  • Strategic partnerships with global pharmaceutical companies
  • +1 moreTrack every material event for Syngene International Limited as it happens. Explore monitoring →
Get alerted when Syngene International Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Syngene International Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Syngene International Limited operates in Contract Research and Manufacturing Services (CDMO/DDMS). See how the rest of the sector scores on the Cyborg framework.

Browse Contract Research and Manufacturing Services (CDMO/DDMS) research →
NEW · MCP server

Ask your AI assistant about Syngene International Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Syngene International Limited and its top competitor on Cyborg Score”
“What did Syngene International Limited do this quarter?”
“Is Syngene International Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Syngene International Limited do?+
Syngene International is India's leading integrated drug discovery, development and manufacturing services (DDMS) provider. The company offers preclinical and clinical services to global pharmaceutical and biotech cli...
What is Syngene International Limited's Cyborg Score?+
Syngene International Limited has a Cyborg Score of 7/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Syngene International Limited's main competitors?+
Named competitors include CDMO Services, CDMO Services, CRO/CDMO Services. The full competitive landscape is in the AskCyborg report.
How can I get the full Syngene International Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Syngene International Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Syngene International Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual